• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

January 7, 2019
Company Drug/Device Medical Condition Status
Pfizer, Inc. PF-06651600 (oral JAK3 inhibitor) moderate to severe alopecia areata Phase II/III trial initiated enrolling 660 subjects
Slayback Pharma LLC Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth ANDA approval granted by the FDA
I-Mab Biopharma TJM2, a humanized immunoglobulin G1 (IgG1) targeting granulocyte-macrophage colony-stimulating factor (GM-CSF) autoimmune and inflammatory diseases IND approval granted by the FDA
Cardiva Medical, Inc. VASCADE MVP Venous Vascular Closure System electrophysiology procedures PMA approval granted by the FDA
Eiger BioPharmaceuticals, Inc. lonafarnib hepatitis delta virus (HDV) infection PRIME (PRIority MEdicines) designation granted by the EMA
Horizon Pharma plc RAVICTI (glycerol phenylbutyrate) Oral Liquid infants younger than two months of age living with a urea cycle disorder (UCD) sNDA approval granted by the FDA
Edwards Lifesciences Corporation SAPIEN 3 Ultra system transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery Approval granted by the FDA
Sanofi and Merck Vaxelis (ready-to-use hexavalent vaccine) prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Haemophilus influenza type b Approval granted by the FDA
Alexion Pharmaceuticals Ultomiris paroxysmal nocturnal hemoglobinuria (PNH) Approval granted by the FDA
Stemline Therapeutics Elzonris blastic plasmacytoid dendritic cell neoplasm (BPDCN) Approval granted by the FDA
Teva Pharmaceutical Industries Ltd. ProAir Digihaler (albuterol sulfate 117 mcg) inhalation powder asthma and COPD Approval granted by the FDA
Acorda Inbrija intermittent treatment of OFF episodes in Parkinson’s disease patients taking Carbidopa/Levodopa Approval granted by the FDA
Merck KEYTRUDA recurrent locally advanced or metastatic Merkel cell carcinoma (MCC) Approval granted by the FDA
Veloxis Pharmaceuticals Envarsus XR (tacrolimus extended-release tablets) organ rejection in kidney transplant patients Approval granted by the FDA
AstraZeneca and Merck LYNPARZA deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer Approval granted by the FDA
Medtronic plc InterStim smart programmer overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive urinary retention Approval granted by the FDA
Celltrion, Inc. and Teva Pharmaceuticals Industries Limited HERZUMA (trastuzumab-pkrb) treatment of HER2-overexpressing breast cancer for certain indications Approval granted by the FDA

 

Upcoming Events

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

  • VaccinewithNeedle-360x240.png

    2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

  • Dominate-360x240.png

    COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing